Does someone in your family have type 1 diabetes? If so, other family members may be at risk for developing diabetes. UCSF is offering a free simple blood test for relatives of people with type 1 diabetes. The test could detect an increased risk for type 1 diabetes up to ten years before symptoms appear.
In August, UCSF’s Mary Sullivan, RN, MSN, C-ANP, CDE received the Diabetes Educator of the Year Award at the American Association of Diabetes Educators (AADE) Annual Convention in Atlanta. This national award sponsored by LifeScan, Inc. honors a diabetes educator who has made a special contribution to the field through dedication, innovation and sensitivity in patient care.
Diabetes Center/QB3 researcher and San Francisco General Hospital endocrinologist, Feroz Papa, MD, PhD, has uncovered a new class of drugs that may prevent death of stressed cells, a mechanism that is thought to underlie diseases such as type 2 diabetes.
Significant progress has been made in the past several years in improving the results of pancreatic islet transplantation for patients with type 1 diabetes. Here at UCSF, we are pursuing three studies that we hope will help patients with diabetes who suffer from hypoglycemic unawareness and poor glucose control.
Chinese Americans are 1.6 times more likely than European Americans to develop type 2 diabetes. Since San Francisco has one of the oldest and largest Chinese communities in the U.S., UCSF is helping to test the effectiveness of culturally specific diabetes management programs for Chinese Americans.
In a series of studies featured recently in the journal Diabetes Care, Dean Schillinger, MD and his team reported success in developing and evaluating an automated telephone self-management support system to reduce diabetes-related health inequalities in vulnerable populations.
Our UCSF research and clinical care employees are a recognized strength of the Diabetes Center. They are igniting innovation, accelerating the pace of scientific discovery, and shaping the future of science and health.
Douglas Hanahan, PhD, a faculty member in both the UCSF Diabetes Center and the UCSF Helen Diller Comprehensive Cancer Center, received one of the highest honors a U.S. scientist can receive – membership to the National Academy of Sciences.
The Vera M. Long Foundation has continued its legacy of support by creating the Vera M. Long Endowed Chair in Diabetes Research. Diabetes Center researcher Christian Vaisse, MD, PhD was recently appointed to this prestigious chair.
Mark Anderson, MD, PhD, has been elected to the American Society for Clinical Investigation (ASCI). This is one of the nation’s oldest and most respected medical honor societies that pays tribute to young physician-scientists. Since 1908, over 2,800 physician-scientists have been elected to the Society for their outstanding records of scholarly achievement in biomedical research.
UCSF jumped to second place among recipients of National Institutes of Health (NIH) research support last year, trailing only Johns Hopkins University in Baltimore.
At a recent UCSF stem cell gathering, Diabetes Center Director Jeffrey Bluestone, PhD compared the effort of transforming stem cells to beta cells to a coast-to-coast road trip from San Francisco to New York. According to Dr. Bluestone, “We’re not in New York yet, but we’re getting close. We’re in Newark.”
Michael McManus, PhD is UCSF’s resident expert in microRNAs, the so called “dark matter” of the genome that are the tiny “switches” that control most of the genes in the body.